Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

The Sequence Alignment/Map format and SAMtools

Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041

Fast and accurate short read alignment with Burrows-Wheeler transform

Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607

Estimating the Dimension of a Model

Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033

MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods

Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr121 · Cited by 40,166

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724

Cancer statistics, 2013

Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825

Circos: An information aesthetic for comparative genomicsPreprint

Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,073

Mutations of the BRAF gene in human cancer

Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660

<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool

Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480

Cell-by-Cell: Unlocking Lung Cancer Pathogenesis

Sinjab, A. F., Rahal, Z., & Kadara, H. N. (2022) · Cancers · doi:10.3390/cancers14143424 · Cited by 19

Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases

Wong, L., Sami, A., & Chelico, L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac1121 · Cited by 18

Analytical Performance Evaluation of a 523-Gene Circulating Tumor DNA Assay for Next-Generation Sequencing–Based Comprehensive Tumor Profiling in Liquid Biopsy Samples

Harter, J., Buth, E., Johänning, J., Battke, F., Kopp, M., Zelba, H., Schulze, M., Ködding, J., & Biskup, S. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.10.001 · Cited by 19

Long range personalized cancer treatment strategies incorporating evolutionary dynamics

Yeang, C., & Beckman, R. A. (2016) · Biology Direct · doi:10.1186/s13062-016-0153-2 · Cited by 18

Mechanisms underlying the heterogeneity of myelodysplastic syndromes

Dussiau, C., & Fontenay, M. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.10.004 · Cited by 19

Inter and intra-tumoral heterogeneity as a platform for personalized therapies in medulloblastoma

Danilenko, M., Clifford, S. C., & Schwalbe, E. C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107828 · Cited by 18

A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies

Li, X., & Thirumalai, D. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0803 · Cited by 18

The Immune Landscape of Non–Small-Cell Lung Cancer: Utility of Cytologic and Histologic Samples Obtained through Minimally Invasive Pulmonary Procedures

Beattie, J., Yarmus, L. B., Wahidi, M. M., Rivera, M. P., Gilbert, C. R., Maldonado, F., Czarnecka, K., Argento, A. C., Chen, A. J., Herth, F. J. F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2539pp · Cited by 18

Correction: A Virus-infected, Reprogrammed Somatic Cell–derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Cancer

Lu, S., Zhang, Z., Du, P., Chard, L. S., Yan, W., Khouri, M. E., Wang, Z., Zhang, Z., Chu, Y., Gao, D., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0850 · Cited by 18

Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma

Ko, J. M. Y., Guo, C., Liu, C., Ning, L., Dai, W., Tao, L., Lo, A. W. I., Wong, C. W.-Y., Wong, Y., Chan, F. S., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01995-0 · Cited by 17

Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy

Yang, F., Wei, H., Li, X., Yu, X., Zhao, Y., Li, L., Li, Y., Xie, L., Wang, S., & Lin, M. (2023) · Insights into Imaging · doi:10.1186/s13244-023-01411-y · Cited by 17

EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature

Yang, Y., Zhang, B., Li, R., Liu, B., & Wang, L. (2016) · Oncology Letters · doi:10.3892/ol.2016.4409 · Cited by 17

P-gp Inhibition by XL019, a JAK2 Inhibitor, Increases Apoptosis of Vincristine-treated Resistant KBV20C Cells with Increased p21 and pH2AX Expression

Cheon, J. H., Kim, J. Y., Lee, B., Kim, H. S., & Yoon, S. (2017) · Anticancer Research · doi:10.21873/anticanres.12136 · Cited by 17

Patient-Derived Organoids in Precision Oncology – Towards a Science of and for the Individual?

Green, S., Dam, M. S., & Svendsen, M. N. (2022) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-74804-3_7 · Cited by 17

Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women’s Cancers

Bartlett, T. E., Jones, A., Goode, E. L., Fridley, B. L., Cunningham, J. M., Berns, E. M. J. J., Wik, E., Salvesen, H. B., Davidson, B., Trope, C. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143178 · Cited by 16

Resistance to epithelial growth factor receptor tyrosine kinase inhibitors in a patient with transformation from lung adenocarcinoma to small cell lung cancer: A case report

Fang, L., He, J., Xia, J., Dong, L., Zhang, X., Chai, Y., Li, Y., Niu, M., Hang, T., & Li, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.6229 · Cited by 19

Next-generation sequencing: hype and hope for development of personalized radiation therapy?

Tinhofer, I., Niehr, F., Konschak, R., Liebs, S., Munz, M., Stenzinger, A., Weichert, W., Keilholz, U., & Budach, V. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0481-x · Cited by 16

Using Large-Scale Genomics Data to Identify Driver Mutations in Lung Cancer: Methods and Challenges

Hudson, A., Wirth, C., Stephenson, N. L., Fawdar, S., Brognard, J., & Miller, C. J. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.60 · Cited by 18

Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules

Pelosi, G., Pellegrinelli, A., Fabbri, A., Tamborini, E., Perrone, F., Settanni, G., Busico, A., Picciani, B., Testi, M. A., Militti, L., et al. (2016) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-1931-z · Cited by 16

Deep sequencing reveals the genomic characteristics of lung adenocarcinoma presenting as ground-glass nodules (GGNs)

Wu, N., Liu, S., Li, J., Hu, Z., Yan, S., Duan, H., Wu, D., Ma, Y., Li, S., Wang, X., et al. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-1086 · Cited by 15

Tools used to assay genomic instability in cancers and cancer meiomitosis

Gantchev, J. K., Ramchatesingh, B. L., Berman-Rosa, M., Sikorski, D., Raveendra, K., Amar, L., Xu, H. H., Villarreal, A. M., Ordaz, D. J. G., & Litvinov, I. V. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00661-z · Cited by 19

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

Stensgaard, S., Thomsen, A., Helstrup, S., Meldgaard, P., & Sørensen, B. S. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-818 · Cited by 15

Chromosomal Instability-Driven Cancer Progression: Interplay with the Tumour Microenvironment and Therapeutic Strategies

Zheng, S., Guerrero, E. N., & Foijer, F. (2023) · Cells · doi:10.3390/cells12232712 · Cited by 18

Clinical translation for targeting DNA damage repair in non-small cell lung cancer: a review

Mao, X., Lee, N. K., Saad, S. E., & Fong, I. L. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-742 · Cited by 16

Exome‐wide single‐base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse

Paisie, C. A., Schrock, M. S., Karras, J. R., Zhang, J., Miuma, S., Ouda, I. M., Waters, C. E., Saldivar, J. C., Druck, T., & Huebner, K. (2016) · Cancer Science · doi:10.1111/cas.12887 · Cited by 16

The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer

Yu, K., Tsai, T.-H., Ho, C., Liao, W., Lin, C., Hsu, C., & Shih, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-24300-7 · Cited by 16

Computer simulations of the signalling network in FLT3 +-acute myeloid leukaemia – indications for an optimal dosage of inhibitors against FLT3 and CDK6

Buetti‐Dinh, A., & Friedman, R. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2145-y · Cited by 16

Histologic transformation of non-small-cell lung cancer in brain metastases

Jiang, M., Zhu, X., Han, X., Jing, H., Han, T., Li, Q., & Ding, X. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-1369-1 · Cited by 16

A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer

Chen, Y., Mao, B., Peng, X., Zhou, Y., Xia, K., Guo, H., Jiang, H. F., Wang, G., & Zhuang, W. (2019) · Journal of Cancer · doi:10.7150/jca.28266 · Cited by 18

Self-generated persistent random forces drive phase separation in growing tumors

Sinha, S., & Thirumalai, D. (2020) · The Journal of Chemical Physics · doi:10.1063/5.0026590 · Cited by 14

Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment

Tseng, J., Hsu, K.-H., Zheng, Z.-R., Yang, T., Chen, K., Huang, Y.-H., Su, K., Yu, S., & Chang, G. (2020) · Oncology · doi:10.1159/000509664 · Cited by 18

The value of cell-free circulating tumour DNA profiling in advanced non-small cell lung cancer (NSCLC) management

Fernandes, M. G. O., Martins, N. A., Machado, J. C., Costa, J. L., & Hespanhol, V. P. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02382-0 · Cited by 16

Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma

Affinito, O., Orlandella, F. M., Luciano, N., Salvatore, M., Salvatore, G., & Franzese, M. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02680-1 · Cited by 16

Immunotherapeutic Transport Oncophysics: Space, Time, and Immune Activation in Cancer

Nizzero, S., Shen, H., Mauro Ferrari, B., & Corradetti, B. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.11.008 · Cited by 16

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcomaPreprint

Chen, K. S.-M., Kwon, W. S., Kim, J., Heo, S. J., Kim, H. S., Kim, H. K., Kim, S. H., Lee, W. S., Chung, H. C., Rha, S. Y., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a000992 · Cited by 16

Of Context, Quality, and Complexity: Fine-Combing Tumor Mutational Burden in Immunotherapy-Treated Cancers

Niknafs, N., Najjar, M., Dennehy, C., Stouras, I., & Anagnostou, V. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0824 · Cited by 16

Lactate Metabolic Reprogramming Mediated by CircRNA–LDHA Complex Facilitates Innate Immune Evasion of Liver Cancer

Shen, H., Liu, B., He, J., Zhao, W., Li, W., Ma, L., Hou, L., Wáng, Y., Jin, C., Chang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202509989 · Cited by 16

Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma

Wen, S. W. C., Andersen, R. F., Petersen, L. M. S., Hager, H., Hilberg, O., Jakobsen, A. K. M., & Hansen, T. F. (2020) · Cancers · doi:10.3390/cancers12123728 · Cited by 15

Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma

Wu, X., Song, P., Guo, L., Ying, J., & Li, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.888951 · Cited by 15

Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma

Mishra, S., Srivastava, P., Pandey, A., Shukla, S., Agarwal, A., & Husain, N. (2023) · Laboratory Investigation · doi:10.1016/j.labinv.2023.100301 · Cited by 15

Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology

Ziogas, D. E., Kyrochristos, I. D., & Roukos, D. H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.07.008 · Cited by 15

Application of large-scale targeted sequencing to distinguish multiple lung primary tumors from intrapulmonary metastases

Duan, J., Ge, M., Peng, J., Zhang, Y., Yang, L., Wang, T., Tian, Q., Rui, Y., Zhang, Y., & Cheng, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-75935-4 · Cited by 15

Comprehensive Mapping of Key Regulatory Networks that Drive Oncogene Expression

Lin, L., Holmes, B. R., Shen, M. W., Kammeron, D., Geijsen, N., Gifford, D. K., & Sherwood, R. I. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108426 · Cited by 14

Next-Generation Sequencing of Lung Cancers

Devarakonda, S. H. K., Masood, A., & Govindan, R. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.08.008 · Cited by 15

Volumetric analysis of intravoxel incoherent motion imaging for assessment of solitary pulmonary lesions

Yuan, M., Zhong, Y., Zhang, Y., Yu, T., Li, H., & Wu, J. (2017) · Acta Radiologica · doi:10.1177/0284185117698863 · Cited by 15

Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine

Han, Y., & Li, J. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0112 · Cited by 15

Commentary on tumor heterogeneity

Popper, H. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.08.07 · Cited by 15

Towards the molecular era of discriminating multiple lung cancers

Wang, Z., Yuan, X., Jiang, G., Li, Y., Yang, F., Wang, J., & Chen, K. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104508 · Cited by 15

S100A4 and its role in metastasis – computational integration of data on biological networks

Buetti‐Dinh, A., Pivkin, I. V., & Friedman, R. (2015) · Molecular BioSystems · doi:10.1039/c5mb00110b · Cited by 14

Possible application of circulating free tumor DNA in non-small cell lung cancer patients

Karachaliou, N., Sosa, A. E., Molina‐Vila, M. Á., Ruiz, M. C., & Rosell, R. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.09.59 · Cited by 14

Mutant‑allele fraction heterogeneity is associated with non‑small cell lung cancer patient survival

Shen, S., Wei, Y., Zhang, R., Du, M., Duan, W., Yang, S., Zhao, Y., Christiani, D. C., & Chen, F. (2017) · Oncology Letters · doi:10.3892/ol.2017.7428 · Cited by 14

Treatment and Prevention of Lung Cancer Using a Virus-Infected Reprogrammed Somatic Cell-Derived Tumor Cell Vaccination (VIReST) Regime

Zhang, Z., Lu, S., Chard, L. S., Wang, Z., Cheng, Z., Zhang, Z., Yan, W., Chu, Y., Gao, D., Wang, N., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01996 · Cited by 14

Cell plasticity in patients with NSCLC: The controversial origins of transformed SCLC

Liang, X., Lin, A., Wang, Q., Zhang, J., & Luo, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112909 · Cited by 14

Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer

Ho, H., Jiang, Y., Chiang, C., Karwowska, S., Yerram, R., Sharma, K., Scudder, S., Chiu, C., Tsai, C., Palma, J. F., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267362 · Cited by 14

EGFR mutation types and abundance were associated with the overall survival of advanced lung adenocarcinoma patients receiving first-line tyrosine kinase inhibitors

Liu, Y., Wang, H., Yang, S., Yang, Y., Wu, Y., He, Z., Ma, S., Mo, Y., Chen, H., Wang, Q., et al. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-755 · Cited by 14

Cancer Evolution–Development: Experience of Hepatitis B Virus–Induced Hepatocarcinogenesis

Liu, W. B., Wu, J., Du, Y., & Cao, G. (2016) · Current Oncology · doi:10.3747/co.23.2836 · Cited by 14

phyC: Clustering cancer evolutionary trees

Matsui, Y., Niida, A., Uchi, R., Mimori, K., Miyano, S., & Shimamura, T. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005509 · Cited by 14

Phosphoenolpyruvate Carboxykinase Maintains Glycolysis-driven Growth in Drosophila Tumors

Hussain, R., Shaukat, Z., Khan, M., Saint, R. B., & Gregory, S. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-11613-2 · Cited by 14

Exceptional Responders Inspire Change: Lessons for Drug Development From the Bedside to the Bench and Back

Chau, N. G., & Lorch, J. H. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0476 · Cited by 14

Spatial heterogeneity in tumor adhesion qualifies collective cell invasion

Prasanna, C. V. S., Jolly, M. K., & Bhat, R. (2024) · Biophysical Journal · doi:10.1016/j.bpj.2024.05.005 · Cited by 13

Spatial intra-tumour heterogeneity and treatment-induced genomic evolution in oesophageal adenocarcinoma: implications for prognosis and therapy

Brosda, S., Aoude, L. G., Bonazzi, V., Patel, K., Lonie, J. M., Belle, C. J., Newell, F., Koufariotis, L. T., Addala, V., Naeini, M. M., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01362-z · Cited by 14

The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era

Costa, J., Membrino, A., Zanchetta, C., Rizzato, S., Cortiula, F., Rossetto, C., Pelizzari, G., Aprile, G., & Macerelli, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413669 · Cited by 13

Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse

Baumann, A., Buribayev, Z., Wolkenhauer, O., Salybekov, A. A., & Wolfien, M. (2025) · Epigenomes · doi:10.3390/epigenomes9010005 · Cited by 18

Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers

Chen, K., Liu, A., Wang, C., Hu, C., Chen, C., Yang, F., Chen, H., Shen, H., Zhang, H., Liu, H., et al. (2025) · Med · doi:10.1016/j.medj.2025.100643 · Cited by 14

Prognostic value of histogram analysis in advanced non-small cell lung cancer: a radiomic study

Virginia, B. M., Faivre, L., Rosellini, S., Ferrara, R., Facchinetti, F., Eva, H., Charles, F., Ammari, S., Michiels, S., Soria, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22316 · Cited by 13

Determinants of Oligonucleotide Selectivity of APOBEC3B

Wagner, J., Demir, Ö., Carpenter, M. A., Aihara, H., Harki, D. A., Harris, R. S., & Amaro, R. E. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00427 · Cited by 13

Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors

Imai, M., Nakamura, Y., Sunami, K., Kage, H., Komine, K., Koyama, T., Amano, T., Ennishi, D., Kanai, M., Kenmotsu, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15504 · Cited by 12

Evolutionary determinants of curability in cancer

Mansur, M. B., deSouza, N. M., Natrajan, R., Abegglen, L. M., Schiffman, J. D., & Greaves, M. F. (2023) · Nature Ecology & Evolution · doi:10.1038/s41559-023-02159-w · Cited by 13

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

Nurminen, A., Jaatinen, S., Taavitsainen, S., Högnäs, G., Lesluyes, T., Ansari‐Pour, N., Tolonen, T. T., Haase, K., Koskenalho, A., Kankainen, M., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01242-y · Cited by 12

Role of Pro-inflammatory Cytokines in Radiation-Induced Genomic Instability in Human Bronchial Epithelial Cells

Werner, E., Wang, H., & Doetsch, P. W. (2015) · Radiation Research · doi:10.1667/rr14045.1 · Cited by 13

Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients

de Bruin, E. C., Whiteley, J. L., Corcoran, C., Kirk, P. M., Fox, J. C., Armisen, J., Lindemann, J. P. O., Schiavon, G., Ambrose, H. J., & Kohlmann, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175779 · Cited by 13

Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma

Eguren‐Santamaría, I., Sánchez-Bayona, R., Patiño‐García, A., Bazo, I. G., & López-Picazo, J. M. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.05.029 · Cited by 13

Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations

Kazdal, D. N., Harms, A., Endris, V., Penzel, R., de Oliveira, C. M. M., Kriegsmann, M., Longuespée, R., Winter, H., Schneider, M. A., Muley, T., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.10.024 · Cited by 14

A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma

Diessner, B. J., Marko, T. A., Scott, R. M., Eckert, A. L., Stuebner, K., Hohenhaus, A. E., Selting, K. A., Largaespada, D. A., Modiano, J. F., & Spector, L. G. (2019) · Cancer Medicine · doi:10.1002/cam4.2177 · Cited by 13

Driver Gene Alterations in Malignant Progression of Gastric Cancer

Dong, Y., Song, N., Wang, J., Shi, L., Zhang, Z., & Du, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.920207 · Cited by 13

A Pilot Study of Baseline Spatial Genomic Heterogeneity in Primary Gastric Cancers Using Multi-Region Endoscopic Sampling

Chao, J., Lee, J., Kim, K., Kang, S. Y., Lee, T., Kim, K., Kim, S. T., Klempner, S. J., & Lee, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00225 · Cited by 12

Resolving tumor evolution: a phylogenetic approach

Li, L., Xie, W., Zhan, L., Wen, S., Luo, X., Xu, S., Cai, Y., Tang, W., Wang, Q., Li, M., et al. (2024) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2024.03.001 · Cited by 14

Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction

Salcedo, A., Tarabichi, M., Buchanan, A., Espiritu, S. M. G., Zhang, H., Zhu, K., Yang, T.-H. O., Leshchiner, I., Anastassiou, D., Guan, Y., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02250-y · Cited by 17

Diagnosis and management of multiple primary lung cancer

Dong, H., Tian, Y., Xin, S., Jiang, S., Guo, Y., Wan, Z., & Han, Y. P. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1392969 · Cited by 12

Heterogeneity in space and time

Errico, A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.186 · Cited by 12

Karyotyping human and mouse cells using probes from single-sorted chromosomes and open source software

Potapova, T., Unruh, J. R., Box, A., Bradford, W. D., Seidel, C. W., Slaughter, B. D., Sivagnanam, S., Wu, Y., & Li, R. (2015) · BioTechniques · doi:10.2144/000114362 · Cited by 12

Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification

Dama, E., Melocchi, V., Colangelo, T., Cuttano, R., & Bianchi, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010108 · Cited by 13

A phylogenetic approach to study the evolution of somatic mutational processes in cancer

Miura, S., Vu, T., Choi, J., Townsend, J. P., Karim, S., & Kumar, S. (2022) · Communications Biology · doi:10.1038/s42003-022-03560-0 · Cited by 12

Game of clones: Battles in the field of carcinogenesis

Rahal, Z., Sinjab, A. F., Wistuba, I. I., & Kadara, H. N. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108251 · Cited by 14

Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC – A systematic review

Samarth, N. H., Gulhane, P., & Singh, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1089320 · Cited by 16

Molecular portraits of lung cancer evolution

Hayes, T. K., & Meyerson, M. M. (2023) · Nature · doi:10.1038/d41586-023-00934-0 · Cited by 12

Semi-synthesis and anti-lung cancer activity evaluation of aryl dihydrothiazol acyl podophyllotoxin ester derivatives

Lin, H., Bai, L., Wang, F., Wu, X., Han, L., Baloch, S. K., Yang, Y., & Wang, X. (2015) · RSC Advances · doi:10.1039/c5ra01871d · Cited by 12

Genomic architecture of lung cancers

Fernandez‐Cuesta, L., & McKay, J. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000251 · Cited by 12

Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics

y Cajal, S. R., Hümmer, S., Peg, V., Matías‐Guiu, X., de Torres, I. M., Castellví, J., Martínez-Sáez, E. A., & Hernández‐Losa, J. (2019) · Histopathology · doi:10.1111/his.13828 · Cited by 12

PET/MRI and genetic intrapatient heterogeneity in head and neck cancers

Clasen, K., Leibfarth, S., Hilke, F. J., Admard, J., Winter, R. M., Welz, S., Gatidis, S., Nann, D., Ossowski, S., Breuer, T., et al. (2020) · Strahlentherapie und Onkologie · doi:10.1007/s00066-020-01606-y · Cited by 12

Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing

Kujur, P. K., Flores, B. C. T., Ramalingam, N., Chinen, L. T. D., & Jeffrey, S. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35805-1_5 · Cited by 12

Radiomic features of primary tumor by lung cancer stage: analysis in BRAF mutated non-small cell lung cancer

Padole, A. M., Singh, R., Zhang, E. W., Mendoza, D. P., Dagogo‐Jack, I., Kalra, M. K., & Digumarthy, S. R. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-347 · Cited by 11

Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing

Xue, L., Li, L., Fan, X., Zhao, Z., Zhou, W., Feng, Z., Liu, L., Hua, L., Li, L., Xue, X., et al. (2020) · Theranostics · doi:10.7150/thno.45311 · Cited by 12

CHRONOCRISIS: When Cell Cycle Asynchrony Generates DNA Damage in Polyploid Cells

Gemble, S., & Basto, R. (2020) · BioEssays · doi:10.1002/bies.202000105 · Cited by 14

Dietary molecules and experimental evidence of epigenetic influence in cancer chemoprevention: An insight

Ullah, M. F., Usmani, S. A., Shah, A., & Abuduhier, F. M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.011 · Cited by 12

Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies

Huang, X., Qiao, Y., Brady, S. W., Factor, R. E., Downs-Kelly, E. P., Farrell, A., McQuerry, J. A., Shrestha, G., Jenkins, D. F., Johnson, W. E., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00989-6 · Cited by 10

Genetic inhibitors of APOBEC3B-induced mutagenesisPreprint

Mertz, T. M., Rice-Reynolds, E., Nguyen, L. T. H., Wood, A. J., Cordero, C., Bray, N., Harcy, V., Vyas, R. K., Mitchell, D., Lobachev, K. S., et al. (2023) · Genome Research · doi:10.1101/gr.277430.122 · Cited by 12

Somatic evolution following cancer treatment in normal tissue

Pich, O., Ward, S., Rowan, A., Naceur‐Lombardelli, C., Shutkever, O., Martínez‐Ruiz, C., Harries, S., Hessey, S., Naidu, B. V., Brenton, J. D., et al. (2025) · Nature · doi:10.1038/s41586-025-09792-4 · Cited by 17

Single-cell and bulk transcriptome analysis reveals tumor cell heterogeneity and underlying molecular program in uveal melanoma

Li, K., Huang, J., Tan, Y., Sun, J., & Zhou, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05831-2 · Cited by 11

Science in Focus: Genomic Instability and its Implications for Clinical Cancer Care

Ahmad, S. S., Ahmed, K., & Venkitaraman, A. R. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.09.001 · Cited by 11

Heterogeneity in space and time

Errico, A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.186 · Cited by 12

Evolution of the Genomic Landscape in Non-Small Cell Lung Cancer

Jamal‐Hanjani, M., Wilson, G. A., de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Rowan, A., Campbell, P. J., & Swanton, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu438.44

The spatiotemporal evolution of early-stage non-small-cell lung cancer.

Wang, S., Zhang, J., Xu, W., Bao, H., Fan, X., Jiang, Y., Wu, X., Wang, X., Shao, Y. W., Xu, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.15_suppl.8539 · Cited by 1

Analysis of intratumor heterogeneity unravels lung cancer evolution

de Bruin, E. C., McGranahan, N., & Swanton, C. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.985549 · Cited by 29

ES12.03 Tumor Heterogeneity

Cooper, W. A. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.123